IDA only vs Mauritania: Access to anti-retroviral drugs, male
IDA only
80.4%
in 2024
Mauritania
97.0%
in 2024
IDA only rank
4th
Mauritania rank
2nd
Access to anti-retroviral drugs, male over time
- IDA only
- Mauritania
How they compare
Mauritania currently reports 97.0% against 80.4% in IDA only, a difference of 16.6%.
That makes Mauritania's figure about 1.2 times IDA only's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Mauritania ahead.
IDA only ranks 4th and Mauritania ranks 2nd of 19 groups.
Across the 3 decades both report, IDA only averaged higher in 2 and Mauritania in 1.
Head to head by decade
| Decade | IDA only | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.7% | 3.7% | 2.0% | IDA only |
| 2010s | 39.9% | 33.4% | 6.5% | IDA only |
| 2020s | 73.0% | 79.4% | 6.4% | Mauritania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, IDA only or Mauritania?
- Mauritania, at 97.0% against 80.4% in IDA only as of 2024.
- What is the difference in access to anti-retroviral drugs, male between IDA only and Mauritania?
- 16.6%, with Mauritania ahead.
- How many years of comparable data are there for IDA only and Mauritania?
- 25 years are reported by both, from 2000 to 2024.
- How do IDA only and Mauritania rank globally for access to anti-retroviral drugs, male?
- IDA only ranks 4th and Mauritania ranks 2nd of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.